Zepbound
Entity.
- Evidence
- 88 documents · 37 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 3 Sept 2026, last seen 10 Nov 2026
- Measured
- 3% of mentions say something specific about it; the rest only name it
- As of
- 14 Nov 2026
Where this comes from
- 24/7 Wall St. · 2026-11-02 · Employers Pepsi, Starbucks and Cigna Are Dropping GLP-1 Coverage. At 65, Medicare May Cover Zepbound for Sleep Apnea or Wegovy for Heart Risk, With Part D Spending Capped… (opens the source in a new tab)
- Clinical Trials Arena · 2026-10-12 · Lilly reports Phase IIIb data on Taltz and Zepbound combination (opens the source in a new tab)
- 24/7 Wall St. · 2026-10-07 · Lilly’s Worst Entry Points Were Its Most Hyped Approvals Mounjaro and Zepbound (opens the source in a new tab)
- Medical Daily · 2026-10-03 · Rhode Island Medicaid Ends Coverage of Wegovy, Zepbound, and Other GLP-1 Drugs Prescribed Only for Weight Loss (opens the source in a new tab)
- Business Model Analyst · 2026-10-02 · Lilly’s New Obesity Combo Beat Zepbound With a Third of the Zepbound (opens the source in a new tab)
- STAT News · 2026-10-01 · STAT+: Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial (opens the source in a new tab)
- Latest Science News -- ScienceDaily · 2026-09-27 · Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat (opens the source in a new tab)
What is claimed about it
- Could not check: We could not count this claim's sources, so we do not say how well it is supported.
- FDA Orders New Vision Loss Warning for Ozempic, Wegovy, Mounjaro and Zepbound Could not check · first reported 9 Nov 2026